Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cells

Journal of Clinical Microbiology

Volumn 40, Issue 2, 2002, Pages 335-340

  Sarmati, Loredana ^a   Nicastri, Emanuele ^a   Parisi, Saverio G ^a   D'Ettorre, Gabriella ^a   Mancino, Giorgio ^a   Narciso, Pasquale ^a   Vullo, Vincenzo ^a   Andreoni, Massimo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; DIDANOSINE; LAMIVUDINE; STAVUDINE; ZIDOVUDINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL ARTICLE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TYPING;

ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; GENOTYPE; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; LEUKOCYTES, MONONUCLEAR; MICROBIAL SENSITIVITY TESTS; MUTATION; PHENOTYPE; REVERSE TRANSCRIPTASE INHIBITORS; SEQUENCE ANALYSIS, DNA;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0036161976     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.2.335-340.2002     Document Type: Article

References (16)

1. Cellular proviral HIV-DNA decline and viral isolation in naive subjects with < 5000 copies/ml of HIV-RNA and > 500 × 10(6)/1 CD4 cells treated with highly active antiretroviral therapy
2. A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy
3. HIV-1 drug resistance in newly infected individuals
4. Phenotypic and genotypic resistance patterns of HIV isolates derived from individuals treated with didanosine and stavudine
5. Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment
6. Drug-resistance genotyping in HIV-1 therapy: The VIRADAPT randomised controlled trial
7. A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs
8. Antiretroviral drug resistance testing in adults with HIV infection
9. Genotypic and phenotypic nevirapine resistance correlates with virological failure during salvage therapy including abacavir and nevirapine
10. Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infection
11. Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapy
12. Reduced Antiretroviral drug susceptibility among patients with primary HIV infection
13. Evidence of stavudine-related phenotypic resistance among zidovudine-pre-treated HIV-1-infected subjects receiving a therapeutic regiment of stavudine plus lamivudine
14. Mutations in retroviral genes associated with drug resistance update 2000-2001
15. Phenotypic assays and sequencing are less sensitive than point mutation assays for the detection of resistance in mixed HIV-1 genotypic populations